BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1907291)

  • 1. Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography.
    Rydberg T; Wåhlin-Boll E; Melander A
    J Chromatogr; 1991 Mar; 564(1):223-33. PubMed ID: 1907291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of glibenclamide in human plasma and urine.
    Emilsson H; Sjöberg S; Svedner M; Christenson I
    J Chromatogr; 1986 Nov; 383(1):93-102. PubMed ID: 3102535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid column and thin-layer chromatographic determination of human serum glibenclamide at therapeutic levels.
    Uihlein M; Sistovaris N
    J Chromatogr; 1982 Jan; 227(1):93-101. PubMed ID: 6799533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network study.
    Naraharisetti SB; Kirby BJ; Hebert MF; Easterling TR; Unadkat JD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(1):34-41. PubMed ID: 17980680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the kinetics of glyburide and its active metabolites in humans.
    Rydberg T; Jönsson A; Melander A
    J Clin Pharm Ther; 1995 Oct; 20(5):283-95. PubMed ID: 8576296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid high-performance liquid chromatography assay of glibenclamide in serum.
    Abdel-Hamid ME; Suleiman MS; el-Sayed YM; Najib NM; Hasan MM
    J Clin Pharm Ther; 1989 Jun; 14(3):181-8. PubMed ID: 2503528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function.
    Jönsson A; Rydberg T; Sterner G; Melander A
    Eur J Clin Pharmacol; 1998 Feb; 53(6):429-35. PubMed ID: 9551701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of glibenclamide in human plasma by solid-phase extraction and high-performance liquid chromatography.
    Valdes Santurio JR; González Porto E
    J Chromatogr B Biomed Appl; 1996 Jul; 682(2):364-70. PubMed ID: 8844432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies.
    Niopas I; Daftsios AC
    J Pharm Biomed Anal; 2002 May; 28(3-4):653-7. PubMed ID: 12008145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics.
    Rydberg T; Jönsson A; Karlsson MO; Melander A
    Br J Clin Pharmacol; 1997 Apr; 43(4):373-81. PubMed ID: 9146849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of metformin, glyburide and its metabolites in plasma and urine of pregnant patients by LC-MS/MS.
    Zhang X; Wang X; Vernikovskaya DI; Fokina VM; Nanovskaya TN; Hankins GD; Ahmed MS
    Biomed Chromatogr; 2015 Apr; 29(4):560-9. PubMed ID: 25164921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of gliclazide in serum by high-performance liquid chromatography using solid-phase extraction.
    Noguchi H; Tomita N; Naruto S; Nakano S
    J Chromatogr; 1992 Dec; 583(2):266-9. PubMed ID: 1478992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatographic determination of glibenclamide in human plasma.
    Othman S; Shaheen O; Jalal I; Awidi A; Al-Turk W
    J Assoc Off Anal Chem; 1988; 71(5):942-4. PubMed ID: 3148612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific and sensitive high-performance liquid chromatographic determination of glyburide.
    Adams WJ; Krueger DS
    J Pharm Sci; 1979 Sep; 68(9):1138-40. PubMed ID: 115986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatographic determination of the nitroimidazole azanidazole in human plasma and urine.
    Brodie RR; Chasseaud LF; Walmsley LM; Darragh A; O'Kelly DA
    J Chromatogr; 1979 Nov; 179(2):301-9. PubMed ID: 541441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes.
    Dahl-Puustinen ML; Alm C; Bertilsson L; Christenson I; Ostman J; Thunberg E; Wikström I
    Br J Clin Pharmacol; 1990 Sep; 30(3):476-80. PubMed ID: 2121211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine.
    Aoki I; Okumura M; Yashiki T
    J Chromatogr; 1991 Nov; 571(1-2):283-90. PubMed ID: 1810958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and relative bioavailability of tablet of micronized glibenclamide in 4 Chinese healthy men.
    Cui HD; Jiang WD; Zhu XX; Guo Y; Karras HO
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):193-7. PubMed ID: 8237389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatographic determination of seratrodast and its metabolites in human serum and urine.
    Ohta R; Amano T; Yamashita K; Motohashi M
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):325-31. PubMed ID: 9518166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of bromazepam in plasma and of its main metabolites in urine by reversed-phase high-performance liquid chromatography.
    Heizmann P; Geschke R; Zinapold K
    J Chromatogr; 1984 Sep; 310(1):129-37. PubMed ID: 6150047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.